At a Glance
| Isopropylphenidate | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (insufflated) | 10–20 mg | 15–30 mg |
| Total Duration | 1.2–2.6 hrs | 1.5–4 hrs |
| Routes | insufflatedoral | insufflated |
Isopropylphenidate, a Stimulants, and 2-FMA, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 24 documented effects in common, with 2 effects unique to Isopropylphenidate and 27 unique to 2-FMA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Isopropylphenidate | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (insufflated) | 10–20 mg | 15–30 mg |
| Total Duration | 1.2–2.6 hrs | 1.5–4 hrs |
| Routes | insufflatedoral | insufflated |
| Effects | 26 documented | 51 documented |
| Level | Isopropylphenidate | 2-FMA |
|---|---|---|
| Threshold | 2 mg | 5 mg |
| Light | 5–10 mg | 5–15 mg |
| Common | 10–20 mg | 15–30 mg |
| Strong | 20–35 mg | 30–50 mg |
| Heavy | 35 mg | 50 mg |
| Level | Isopropylphenidate | 2-FMA |
|---|---|---|
| Threshold | 2 mg | 5 mg |
| Light | 5–15 mg | 5–15 mg |
| Common | 15–25 mg | 15–30 mg |
| Strong | 25–45 mg | 30–50 mg |
| Heavy | 45 mg | 50 mg |
Isopropylphenidate
2-FMA
Isopropylphenidate
2-FMA
No direct interaction data available between these substances. This does not mean the combination is safe.